Université de Paris, F-75015, Paris, France.
Department of Radiology, Assistance Publique Hôpitaux des Hôpitaux de Paris (AP-HP), Hôpital Européen Georges-Pompidou (HEGP), Paris, France.
Eur Radiol. 2021 Nov;31(11):8354-8363. doi: 10.1007/s00330-021-07938-2. Epub 2021 Apr 29.
Chest CT has been widely used to screen and to evaluate the severity of COVID-19 disease in the early stages of infection without severe acute respiratory syndrome, but no prospective data are available to study the relationship between extent of lung damage and short-term mortality. The objective was to evaluate association between standardized simple visual lung damage CT score (vldCTs) at admission, which does not require any software, and 30-day mortality.
In a single-center prospective cohort of COVID-19 patients included during 4 weeks, the presence and extent of ground glass opacities(GGO), consolidation opacities, or both of them were visually assessed in each of the 5 lung lobes (score from 0 to 4 per lobe depending on the percentage and out of 20 per patient = vldCTs) after the first chest CT performed to detect COVID-19 pneumonia.
Among 210 confirmed COVID-19 patients, the number of survivors and non-survivors was 162 (77%) and 48 (23%), respectively at 30 days. vldCTs was significantly higher in non-survivors, and the AUC of vldCTs to distinguish survivors and non-survivors was 0.72 (95%CI 0.628-0.807, p < 0.001); the best cut-off vldCTs value was 7. During follow-up, significant differences in discharges and 30-day mortality were observed between patients with vldCTs ≥ 7 versus vldCTs < 7: (98 [85.2%] vs 49 [51.6%]; p < 0.001 and 36 [37.9%] vs 12 [12.4%]; p < 0.001, respectively. The 30-day mortality increased if vldCTs ≥ 7 (HR, 3.16 (1.50-6.43); p = 0.001), independent of age, respiratory rate and oxygen saturation levels, and comorbidities at admission.
By using chest CT in COVID-19 patients, extensive lung damage can be visually assessed with a score related to 30-day mortality independent of conventional risk factors of the disease.
• In non-selected COVID-19 patients included prospectively during 4 weeks, the extent of ground glass opacities(GGO) and consolidation opacities evaluated by a simple visual score was related to 30-day mortality independent of age, respiratory rate, oxygen saturation levels, comorbidities, and hs-troponin I level at admission. • This severity score should be incorporated into risk stratification algorithms and in structured chest CT reports requiring a standardized reading by radiologists in case of COVID-19.
胸部 CT 已广泛用于筛查和评估无严重急性呼吸综合征感染早期 COVID-19 疾病的严重程度,但尚无前瞻性数据研究肺损伤程度与短期死亡率之间的关系。本研究的目的是评估入院时标准化简单视觉肺部损伤 CT 评分(vldCTs)与 30 天死亡率之间的关系,该评分无需任何软件即可获得。
在 4 周内进行的一项 COVID-19 患者的单中心前瞻性队列研究中,在首次胸部 CT 检查以检测 COVID-19 肺炎后,在每个 5 个肺叶中(根据百分比,每个肺叶的评分从 0 到 4 分,每个患者的评分总计 20 分=vldCTs)对磨玻璃影(GGO)、实变影或两者均进行视觉评估。
在 210 例确诊的 COVID-19 患者中,30 天的幸存者和非幸存者分别为 162 例(77%)和 48 例(23%)。非幸存者的 vldCTs 明显更高,vldCTs 区分幸存者和非幸存者的 AUC 为 0.72(95%CI 0.628-0.807,p<0.001);最佳截断值 vldCTs 为 7。在随访期间,vldCTs≥7 与 vldCTs<7 的患者在出院率和 30 天死亡率方面存在显著差异:(98[85.2%]与 49[51.6%];p<0.001 和 36[37.9%]与 12[12.4%];p<0.001)。如果 vldCTs≥7(HR,3.16(1.50-6.43);p=0.001),则 30 天死亡率会增加,与年龄、呼吸频率和血氧饱和度水平以及入院时的合并症无关。
通过对 COVID-19 患者进行胸部 CT 检查,可以使用与 30 天死亡率相关的视觉评分来评估广泛的肺部损伤,独立于疾病的常规危险因素。
在 4 周内前瞻性纳入的非选择性 COVID-19 患者中,通过简单的视觉评分评估磨玻璃影(GGO)和实变影的程度与 30 天死亡率相关,与年龄、呼吸频率、血氧饱和度水平、合并症以及入院时的高敏肌钙蛋白 I 水平无关。这种严重程度评分应纳入风险分层算法,并在结构化胸部 CT 报告中使用,以便放射科医生进行标准化阅读,以备 COVID-19 之用。